MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-18-0011084
Emil Pharmaceutical Industries Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹232.55 Cr
▲ 10% YoY
Net profit · FY 2025
₹31.57 Cr
Net margin 13.6%
EBITDA · FY 2025
₹52.93 Cr
EBITDA margin 22.8%
Authorised capital
₹34.15 Cr
Registered with MCA
Paid-up capital
₹21.33 Cr
Issued & subscribed
Open charges
₹213 Cr
Satisfied ₹88.46 Cr
Company age
40 yrs
Est. 1986
Employees · EPFO
607
Provident fund records
About Emil Pharmaceutical Industries Private Limited
Data last updated:
Emil Pharmaceutical Industries Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 May 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1986PTC039809. Its GSTIN is 27AAACE0922A1ZF (Maharashtra).
The company has an authorised share capital of ₹34.15 Cr and a paid-up capital of ₹21.33 Cr. It is led by directors including Manjiri Anil Devdhar and Abhijit Rajendra Gole.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 101 Mangalamkulupwadi Borivali E, Mumbai, Maharashtra, India – 400066.
As per the financials filed for FY 2025, the company reported a revenue of ₹232.55 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹31.57 Cr (net margin 13.6%) and EBITDA of ₹52.93 Cr (EBITDA margin 22.8%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 7% over five years.
The company has about 607 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Emil Pharmaceuticals. As per MCA filings, the company has open charges of ₹213 Cr and satisfied charges of ₹88.46 Cr on record. Court records list 11 cases involving the company, including 6 filed by the company and 5 filed against it; 4 cases are pending. The company has 13 deals on record (9 secondary share transfers, 4 funding rounds), with disclosed funding of ₹75.47 Cr; the latest was in August 2024. Its 3 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 smaller; the largest is Axa Parenterals Limited with revenue of ₹231.46 Cr.
Emil Pharmaceutical Industries Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-18-0011084). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website emilpharma.in.
Company details
CIN U24230MH1986PTC039809
Registration Number 039809
Incorporation Date 13 May 1986
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-18-0011084
Key People
Manjiri Anil Devdhar Director Abhijit Rajendra Gole Director Mayur Anand Sirdesai Director Recognitions & Rankings of Emil Pharmaceutical Industries
Contact details
Emil Pharmaceutical Industries Private Limited's registered office is in Mumbai, Maharashtra. Its website is emilpharma.in. Its e-mail address is in the company report.
- Email
- Website
- Registered Address101 Mangalamkulupwadi Borivali E, Mumbai, Maharashtra, India – 400066
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Emil Pharmaceutical Industries Private Limited, buy the company report.
Comprehensive company report
Emil Pharmaceutical Industries Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Emil Pharmaceutical Industries operates one associated brand: Emil Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products are manufactured by Emil Pharmaceuticals for global markets. | emilpharma.in |
Business activity
The main business activity of Emil Pharmaceutical Industries is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Emil Pharmaceutical Industries Private Limited, buy the company report.
Financials of Emil Pharmaceutical Industries Private Limited
FY 2024 filings availableEmil Pharmaceutical Industries Private Limited reported revenue of ₹232.55 Cr (up 10% YoY) for FY 2025.
Revenue · FY 2025
₹232.55 Cr ▲ 10%
Net profit · FY 2025
₹31.57 Cr margin 13.6%
EBITDA · FY 2025
₹52.93 Cr margin 22.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 1%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 52%
3 years · compounded
▼ 8%
5 years · compounded
▲ 15%
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 10% growth in the latest year. EBITDA rose 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹52.93 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹31.57 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.8% | ||||
| Net Profit Margin | 13.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Emil Pharmaceutical Industries Private Limited, buy the company report.
Board of directors of Emil Pharmaceutical Industries Private Limited
Emil Pharmaceutical Industries has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manjiri Anil Devdhar | Director | 24 Feb 2004 | 22 Years 8 Months | Current |
| Abhijit Rajendra Gole Also directs: Avance Research Private Limited | Director | 19 Aug 2024 | 2 Years 2 Months | Current |
| Mayur Anand Sirdesai Also directs: Sicp Investment Advisors India LLP, Globela Pharma Private Limited, Cyrix Healthcare Private Limited and 4 more | Director | 17 Apr 2023 | 3 Years 6 Months | Current |
| Sumegha Sanjiv Patange | Director | 24 Feb 2004 | 22 Years 8 Months | Current |
| Tushar Anil Korday | Director | 13 May 1986 | 40 Years 5 Months | Current |
Peer comparison
Emil Pharmaceutical Industries Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Emil Pharmaceutical Industries Private Limitedthis company | ₹232.55 Cr (FY 2025) | ₹31.57 Cr | 13.6% | 10.0% | 607 | Mumbai, Maharashtra, India |
| Axa Parenterals Limited | ₹231.46 Cr (FY 2025) | 6.0% | Delhi, India | |||
| Dosch Pharmaceuticals Private Limited | ₹229.86 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Medopharm Private Limited | ₹229.32 Cr (FY 2025) | -9.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Emil Pharmaceutical Industries Private Limited, buy the company report.
Auditor
Emil Pharmaceutical Industries Private Limited is audited by Anil Thakrar & Co for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Anil Thakrar & Co | FY 2024 | 113880W |
Shareholding
The shareholding of Emil Pharmaceutical Industries Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Emil Pharmaceutical Industries Private Limited, buy the company report.
Charges & borrowings
Open charges
₹213 Cr
Satisfied charges
₹88.46 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Jul 2024 | 100963643 | Others | ₹25 Cr | Open | |
| 20 Apr 2024 | 100906887 | Hdfc Bank Limited | ₹53 Cr | Open | |
| 12 Feb 2024 | 100862176 | Others | ₹7 Cr | Open | |
| 12 Feb 2024 | 100862168 | Others | ₹33 Cr | Open | |
| 19 Oct 2023 | 100810359 | Axis Bank Limited | ₹45 Cr | Open |
To see the full charge records of Emil Pharmaceutical Industries Private Limited, buy the company report.
Total charge records: 26 View all charges
Deals & funding
Emil Pharmaceutical Industries Private Limited has 13 deals on record (9 secondary share transfers, 4 funding rounds), with disclosed funding of ₹75.47 Cr; the latest was in August 2024.
Total deals
13
Secondary share transfers
9
Funding rounds
4
Disclosed funding
₹75.47 Cr
Deals on record (5 of 13)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2024 | Funding round | ₹3.3 Cr | Investors: Emil Holdings Private Limited , 3 individuals |
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Sanjiv Rajaram Patange HUF, 2 individuals |
| Apr 2023 | Secondary share transfer | Undisclosed | Buyer: Somerset Indus Capital Partners Seller: Sanjiv Rajaram Patange HUF, 3 individuals |
| Apr 2023 | Funding round | ₹71.73 Cr | Investors: Somerset Indus Capital Partners |
To see the full deal history of Emil Pharmaceutical Industries Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Emil Pharmaceutical Industries Private Limited has 11 court cases on record: 6 filed by Emil Pharmaceutical Industries, 5 filed against it. 4 cases are pending and 7 are disposed.
Total cases
11
Filed by the company
6
Filed against the company
5
Pending
4
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 2 | 1 |
| High courts | 3 | 3 | 3 |
| NCLT | 2 | 0 | 0 |
Cases on record (5 of 11)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ludhiana, Punjab | Commercial suit | Filed against the company by State Through Drugs Inspector | Pending |
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Sun Pharmaceuticals Industries Ltd. | Pending |
| High Court, MAHARASHTRA | Court case (LPETN) | Filed against the company by Sun Pharmaceuticals Industries Ltd. | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Sun Pharmaceuticals Industries Ltd. | Pending |
| District court, Ludhiana, Punjab | Court case (CRR) | Filed by the company against an individual | Disposed |
To see the full case history of Emil Pharmaceutical Industries Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Emil Pharmaceutical Industries Private Limited was last rated by Crisil on 29 Jan 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 29 Jan 2021 |
To see the full credit ratings and regulatory alerts of Emil Pharmaceutical Industries Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Emil Pharmaceutical Industries Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Emil Pharmaceutical Industries Private Limited has a workforce of 607 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
607
Active EPFO establishments
1
Employee growth
48%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 607 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Emil Pharmaceutical Industries Private Limited, buy the company report.
GST
Emil Pharmaceutical Industries has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACE0922A1ZF | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Emil Pharmaceutical Industries Private Limited, buy the company report.
Recent activity
Emil Pharmaceutical Industries Private Limited has 9 board changes on record since 1986: 5 appointments and 4 cessations. The latest: Abhijit Rajendra Gole ceased to be Additional Director on 29 Sep 2024.
Charges
A charge registered on 09 Sep 2020 via Charge ID 100408361 with Others was fully satisfied on 04 Jun 2025.
Charges
A charge registered on 05 Aug 2016 via Charge ID 100061660 with Others was fully satisfied on 04 Jun 2025.
Charges
A charge with Others of Rs. 25.00 Cr registered on 26 Jul 2024 with Charge ID 100963643 was modified on 16 Jan 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 53.00 Cr registered on 20 Apr 2024 with Charge ID 100906887 was modified on 16 Jan 2025.
Charges
A charge with Others of Rs. 7.00 Cr registered on 12 Feb 2024 with Charge ID 100862176 was modified on 16 Jan 2025.
Charges
A charge with Others of Rs. 33.00 Cr registered on 12 Feb 2024 with Charge ID 100862168 was modified on 16 Jan 2025.
Charges
A charge with Others of Rs. 35.00 Cr registered on 05 Aug 2016 with Charge ID 100069184 was modified on 16 Jan 2025.
Charges
A charge registered on 08 Sep 2020 via Charge ID 100388205 with Others was fully satisfied on 17 Dec 2024.
Charges
A charge registered on 21 Apr 2023 via Charge ID 100712078 with Others was fully satisfied on 24 Oct 2024.
AGM
Emil Pharmaceutical Industries Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Abhijit Rajendra Gole ceased to be Additional Director.
Appointed
Abhijit Rajendra Gole was appointed as Director.
63 earlier events are in the company report.
Frequently asked questions
Emil Pharmaceutical Industries is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 May 1986 (40+ years old) and is registered under CIN U24230MH1986PTC039809.
Emil Pharmaceutical Industries has 5 current directors:
- Manjiri Anil Devdhar - Director
- Abhijit Rajendra Gole - Director
- Mayur Anand Sirdesai - Director
- Sumegha Sanjiv Patange - Director
- Tushar Anil Korday - Director
The latest financial statements of Emil Pharmaceutical Industries on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Emil Pharmaceutical Industries is 27AAACE0922A1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Emil Pharmaceutical Industries is U24230MH1986PTC039809. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emil Pharmaceutical Industries has 11 court cases on record: 6 filed by the company and 5 filed against it. 4 are pending. Most are in the district courts.
Emil Pharmaceutical Industries was incorporated on 13 May 1986, making it 40+ years old. It is registered with the Registrar of Companies, Mumbai.
Emil Pharmaceutical Industries has 13 deals on record (9 secondary share transfers, 4 funding rounds), with disclosed funding of ₹75.47 Cr; the latest was in August 2024.
The peers of Emil Pharmaceutical Industries by revenue are Axa Parenterals Limited, Dosch Pharmaceuticals Private Limited, Medopharm Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Abhijit Rajendra Gole ceased to be Additional Director on 29 Sep 2024. Abhijit Rajendra Gole was appointed as Director on 19 Aug 2024. Rajendra Fattesinh Gole ceased to be Director on 16 Aug 2024. Emil Pharmaceutical Industries has 9 board changes on record in total.
Yes, Emil Pharmaceutical Industries is registered as an MSME under Udyam registration (number: UDYAM-MH-18-0011084).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages